MD, filed suit against Sentara Healthcare over its ban of certain COVID treatments, a judge in Virginia granted in part Sentara's motion to dismiss the case, but allowed one of Marik's claims against the health system to proceed, in an order dated November 23.
The ban on certain COVID-19 treatments has had a direct impact on the use of Marik's MATH+ Hospital Treatment Protocol, which includes ivermectin.
Though a spokesperson for Sentara previously told MedPage Today that it did not seek the retraction, JICM noted that the retraction followed receipt of communication from Sentara Norfolk General Hospital "Raising concerns about the accuracy of COVID-19 hospital mortality data reported in the article pertaining to Sentara."
Counsel for Marik wrote in a November 22 letter to the judge that Marik had arrived to work at the Sentara Norfolk General Hospital ICU 2 days after a November 18 court hearing to find an unexpected note from Sentara on his desk.
At the hearing, "Sentara expressly represented to this court that it would not discipline Dr. Marik in any way for informing his COVID patients that Sentara was preventing him from giving them alternative treatments that are, in his medical judgment, safe, potentially life-saving, and medically appropriate for them," legal counsel for Marik wrote in the letter.
A spokesperson for Sentara told MedPage Today in an email that, in accordance with state statutes and consistent with hospital policies, Sentara cannot comment on any medical staff proceedings.
"We are appreciative of the court's ruling on Dr. Marik's request for preliminary injunction regarding Sentara Healthcare's COVID-19 protocols. Sentara Healthcare is committed to delivering the highest quality of care to all patients at Sentara facilities. We understand some community members might see conflicting articles based on misinformation available online, but we want to assure our patients and community members that our treatment guidelines are extensively reviewed by multi-disciplinary groups of clinicians using the latest medical literature, care standards and expertise available," the spokesperson said in a statement.
https://www.medpagetoday.com/special-reports/exclusives/95939
No comments:
Post a Comment